中南米の皮下注射器と針の市場規模、シェア、動向分析レポート タイプ別(針、注射器、コンビネーション)、地域別、セグメント別予測、2023年~2030年Latin America Hypodermic Syringes And Needles Market Size, Share & Trends Analysis Report By Type (Needles, Syringes, Combination), By Region, And Segment Forecasts, 2023 - 2030 ラテンアメリカ 皮下注射器・注射針市場の成長と動向 中南米の皮下注射器と針の市場規模は、2030年には3億5,059万米ドルに達すると予測されています。2023年から2030年にかけての年平均成長率は5.7%で拡大する... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーラテンアメリカ 皮下注射器・注射針市場の成長と動向中南米の皮下注射器と針の市場規模は、2030年には3億5,059万米ドルに達すると予測されています。2023年から2030年にかけての年平均成長率は5.7%で拡大すると予測されています。集団予防接種プログラムの増加や、さまざまな慢性疾患に関する意識の高まりが、皮下注射器・針市場の需要を押し上げる要因となっています。 さらに、WHOや国連などの政府機関が、病気の感染を減らし、安全な薬物送達の実践に関する意識を高めるための取り組みを強化していることも、業界の成長につながると期待されています。これらの組織は、安全な薬物送達のためにいくつかのイニシアチブをとっています。これらの機関が実施するプログラムには、注射針と注射器のプログラム、性感染症の予防と治療、標的情報、注射薬使用者(IDU)とその性的パートナーに対する教育・コミュニケーションなどがあります。 COVID-19のパンデミックは、死亡率の低下やウイルス感染リスクのある患者の重症化を抑制するためのワクチン需要の増加により、市場に好影響を与えた。注射器と注射針の需要が急増し、多くの企業が生産能力を大幅に増強する必要がありました。COVID-19の新たな波が予想され、ブースター投与の導入に継続的に取り組む製薬会社が増えていることから、同市場は予測期間中も大きな成長を遂げると予想されます。 中南米の皮下注射器と注射針市場レポートハイライト - 注射針と比較して普及率が高く、価格も高いため、2022年は注射器分野が市場を支配した - インスリンを投与するためにこれらの製品の採用が増加していることから、2022年にはコンビネーション部門が2番目に高いシェアを占めています。 - ブラジルは、COVID-19の患者数が多く、他の国と比較して医療施設が充実していることから、2022年の市場シェアは最高となりました。 - 疾病の発生件数が増加していることから、ベネズエラは予測期間中に最大限の成長を遂げると予想される。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Type 1.1.2. Regional scope 1.1.3. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.2. Approach 1: Commodity flow approach 1.6.3. Volume price analysis (Model 2) 1.6.4. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Type Outlook 2.2.2. Regional Outlook 2.3. Competitive Insights Chapter 3. Latin America Hypodermic Syringes and Needles Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Rise in the prevalence of diabetes, asthma, and other serious allergies 3.4.1.2. Increase in the number of initiatives by government organizations 3.4.1.3. Impact of Covid-19 pandemic. 3.4.2. Market restraint analysis 3.4.2.1. Frequent product recalls 3.4.2.2. Presence of alternatives 3.5. Latin America Hypodermic Syringes and Needles Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Latin America Hypodermic Syringes and Needles: Type Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Needles 4.1.2. Syringes 4.1.3. Combination 4.2. Type Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Latin America Hypodermic Syringes and Needles Market by Type Outlook 4.5. Market Product & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Needles 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.2. 16-18G 4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.3. 19-21G 4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.4. 22-25G 4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.5. 26-29G 4.5.1.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.6. 30-32G 4.5.1.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2. Syringes 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.2. 1-5ml 4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.3. 5-10ml 4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.4. 11-15ml 4.5.2.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.5. 16-20ml 4.5.2.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.6. 21-25ml 4.5.2.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.7. 26-30ml 4.5.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.8. 31-35ml 4.5.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.9. 36-40ml 4.5.2.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.10. 41-45ml 4.5.2.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.11. 46-50ml 4.5.2.11.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.3. Combination 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) Chapter 5. Latin America Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis 5.1. Regional market share analysis, 2022 & 2030 5.2. Regional Market Dashboard 5.3. Global Regional Market Snapshot 5.4. Regional Market Share and Leading Players, 2022 5.4.1. Latin America 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 5.5.1. Latin America 5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030: 5.7. Latin America 5.7.1. Brazil 5.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.2. Mexico 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.3. Argentina 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.4. Colombia 5.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.5. Chile 5.7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.6. Uruguay 5.7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.7. Venezuela 5.7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.8. Bolivia 5.7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.9. Peru 5.7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.10. Ecuador 5.7.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) Chapter 6. Competitive Landscape 6.1. Recent Developments & Impact Analysis, By Key Market Participants 6.2. Company/Competition Categorization 6.2.1. Innovators 6.2.2. Market Leaders 6.2.3. Emerging Players 6.3. Vendor Landscape 6.3.1. List of key distributors and channel partners 6.3.2. Key customers 6.3.3. Key company market share analysis, 2022 6.3.4. Cardinal Health Inc. 6.3.4.1. Company overview 6.3.4.2. Financial performance 6.3.4.3. Product benchmarking 6.3.4.4. Strategic initiatives 6.3.5. Terumo Corporation 6.3.5.1. Company overview 6.3.5.2. Financial performance 6.3.5.3. Product benchmarking 6.3.5.4. Strategic initiatives 6.3.6. BD 6.3.6.1. Company overview 6.3.6.2. Financial performance 6.3.6.3. Product benchmarking 6.3.6.4. Strategic initiatives 6.3.7. Nipro Corporation 6.3.7.1. Overview 6.3.7.2. Financial performance 6.3.7.3. Product benchmarking 6.3.7.4. Strategic initiatives 6.3.8. B.Braun Melsungen 6.3.8.1. Company overview 6.3.8.2. Financial performance 6.3.8.3. Product benchmarking 6.3.8.4. Strategic initiatives 6.3.9. Smiths Medical, Inc. 6.3.9.1. Company overview 6.3.9.2. Financial performance 6.3.9.3. Product benchmarking 6.3.9.4. Strategic initiatives 6.3.10. Lifelong Meditech Private Limited 6.3.10.1. Company overview 6.3.10.2. Financial performance 6.3.10.3. Product benchmarking 6.3.10.4. Strategic initiatives 6.3.11. Exelint International, Co. 6.3.11.1. Company overview 6.3.11.2. Financial performance 6.3.11.3. Product benchmarking 6.3.11.4. Strategic initiatives 6.3.12. Vitrex Medical A/S 6.3.12.1. Company overview 6.3.12.2. Financial performance 6.3.12.3. Product benchmarking 6.3.12.4. Strategic initiatives 6.3.13. Retractable Technologies, Inc. 6.3.13.1. Company overview 6.3.13.2. Financial performance 6.3.13.3. Product benchmarking 6.3.13.4. Strategic initiatives
SummaryLatin America Hypodermic Syringes and Needles Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Type 1.1.2. Regional scope 1.1.3. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.2. Approach 1: Commodity flow approach 1.6.3. Volume price analysis (Model 2) 1.6.4. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Type Outlook 2.2.2. Regional Outlook 2.3. Competitive Insights Chapter 3. Latin America Hypodermic Syringes and Needles Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Rise in the prevalence of diabetes, asthma, and other serious allergies 3.4.1.2. Increase in the number of initiatives by government organizations 3.4.1.3. Impact of Covid-19 pandemic. 3.4.2. Market restraint analysis 3.4.2.1. Frequent product recalls 3.4.2.2. Presence of alternatives 3.5. Latin America Hypodermic Syringes and Needles Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Latin America Hypodermic Syringes and Needles: Type Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Needles 4.1.2. Syringes 4.1.3. Combination 4.2. Type Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Latin America Hypodermic Syringes and Needles Market by Type Outlook 4.5. Market Product & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Needles 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.2. 16-18G 4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.3. 19-21G 4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.4. 22-25G 4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.5. 26-29G 4.5.1.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.1.6. 30-32G 4.5.1.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2. Syringes 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.2. 1-5ml 4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.3. 5-10ml 4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.4. 11-15ml 4.5.2.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.5. 16-20ml 4.5.2.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.6. 21-25ml 4.5.2.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.7. 26-30ml 4.5.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.8. 31-35ml 4.5.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.9. 36-40ml 4.5.2.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.10. 41-45ml 4.5.2.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.2.11. 46-50ml 4.5.2.11.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) 4.5.3. Combination 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million) Chapter 5. Latin America Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis 5.1. Regional market share analysis, 2022 & 2030 5.2. Regional Market Dashboard 5.3. Global Regional Market Snapshot 5.4. Regional Market Share and Leading Players, 2022 5.4.1. Latin America 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 5.5.1. Latin America 5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030: 5.7. Latin America 5.7.1. Brazil 5.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.2. Mexico 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.3. Argentina 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.4. Colombia 5.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.5. Chile 5.7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.6. Uruguay 5.7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.7. Venezuela 5.7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.8. Bolivia 5.7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.9. Peru 5.7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 5.7.10. Ecuador 5.7.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) Chapter 6. Competitive Landscape 6.1. Recent Developments & Impact Analysis, By Key Market Participants 6.2. Company/Competition Categorization 6.2.1. Innovators 6.2.2. Market Leaders 6.2.3. Emerging Players 6.3. Vendor Landscape 6.3.1. List of key distributors and channel partners 6.3.2. Key customers 6.3.3. Key company market share analysis, 2022 6.3.4. Cardinal Health Inc. 6.3.4.1. Company overview 6.3.4.2. Financial performance 6.3.4.3. Product benchmarking 6.3.4.4. Strategic initiatives 6.3.5. Terumo Corporation 6.3.5.1. Company overview 6.3.5.2. Financial performance 6.3.5.3. Product benchmarking 6.3.5.4. Strategic initiatives 6.3.6. BD 6.3.6.1. Company overview 6.3.6.2. Financial performance 6.3.6.3. Product benchmarking 6.3.6.4. Strategic initiatives 6.3.7. Nipro Corporation 6.3.7.1. Overview 6.3.7.2. Financial performance 6.3.7.3. Product benchmarking 6.3.7.4. Strategic initiatives 6.3.8. B.Braun Melsungen 6.3.8.1. Company overview 6.3.8.2. Financial performance 6.3.8.3. Product benchmarking 6.3.8.4. Strategic initiatives 6.3.9. Smiths Medical, Inc. 6.3.9.1. Company overview 6.3.9.2. Financial performance 6.3.9.3. Product benchmarking 6.3.9.4. Strategic initiatives 6.3.10. Lifelong Meditech Private Limited 6.3.10.1. Company overview 6.3.10.2. Financial performance 6.3.10.3. Product benchmarking 6.3.10.4. Strategic initiatives 6.3.11. Exelint International, Co. 6.3.11.1. Company overview 6.3.11.2. Financial performance 6.3.11.3. Product benchmarking 6.3.11.4. Strategic initiatives 6.3.12. Vitrex Medical A/S 6.3.12.1. Company overview 6.3.12.2. Financial performance 6.3.12.3. Product benchmarking 6.3.12.4. Strategic initiatives 6.3.13. Retractable Technologies, Inc. 6.3.13.1. Company overview 6.3.13.2. Financial performance 6.3.13.3. Product benchmarking 6.3.13.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |